A Calling to Save Lives Through the Marvels of Organ Technology
This Changes Everything.
We’re Not Waiting On Miracles.
We’re Engineering Them.
Together with our clinical partners, we’re working to redefine what’s possible in the field of organ technology. Doing that takes collaboration, knowledge sharing, and mutual support as we grow together with the common goal of saving lives through advances in organ care.
Led by Science. From the Start.
2002
Co-Founder Prof. Peter Friend and colleagues publish the first NMP paper.
2008
OrganOx is spun out independently from University of Oxford.
2013
OrganOx begins product development on metra for liver.
2016
OrganOx receives CE mark for the metra system.
2021
OrganOx metra gains FDA approval for liver transplants in the U.S.
2026
OrganOx joins Terumo Group, entering a new era of global impact.
A New Era
A New Era with Terumo Group
OrganOx is proud to be part of Terumo Group, a global leader in medical innovation. United by a shared mission to contribute to society through healthcare, we remain dedicated to transforming the future of organ transplantation. This partnership brings new opportunities to accelerate innovation, expand access, and increase our global impact—bringing life-saving technology to more patients worldwide.
Our team, products, and commitment to you remain unchanged, and operations continue as usual. You can expect the same dedication, expertise, and support you’ve always trusted.
Together, we are advancing in this new era of progress and purpose. Thank you for your continued partnership as we make every organ count.
Our Heritage of Academic Rigor
Built on a Foundation of Scientific Research
The academic discipline we bring to our mission dates all the way back to our beginnings in the Innovation Lab at Oxford University. There, our co-founders combined their surgical and engineering expertise to focus on extracorporeal support for patients with liver disease.
Following where the science led, they developed a breakthrough solution:
Normothermic
Machine
Perfusion
Machine
Perfusion
The world’s first normothermic machine perfusion (NMP) device for liver transplantation1 was an achievement that changed the course of organ technology.
A Part of Terumo
A Terumo Group Company
Terumo is a global medical innovation company. Guided by an unwavering commitment to patients, and driven by the passion of our associates, we strive to fulfill our Group Mission of “Contributing to Society through Healthcare.” Founded in Tokyo in 1921, we provide a comprehensive range of solutions in the fields of therapeutic procedures, hospital operations, and life sciences in more than 160 countries and regions.
As a proud member of the Terumo Group, OrganOx shares this mission and brings it to life through our shared promise and values.
Group Mission
Contributing to Society through Healthcare
Our Promise
Everything starts from our unwavering commitment to patients. Listening sincerely to their needs and understanding deeply their hopes and aspirations, we boldly pursue innovative ways to help enhance the lives of patients around the world.
Core Values
In everything we do, we are guided by five shared values:
Respect – Appreciative of others
Integrity – Guided by our mission
Care – Empathetic to patients
Quality – Committed to excellence
Creativity – Striving for innovation
To learn more about the Terumo Group Identity and our Code of Conduct, please visit the Terumo Global Website.
Future-Focused Leadership
Today, as we continue to push the field of organ technology forward, the work of our founders is driven and amplified by an extraordinary leadership team, bringing together deep expertise in healthcare, engineering, and medical technology.
From Our Newsroom
Keep up to date with the latest OrganOx updates and recent news in organ transplantation.
- Ravikumar, R., Jassem, W., Mergental, H., Heaton, N., Mirza, D., Perera, M. T. P. R., & Friend, P. J. (2016). Liver transplantation after ex vivo normothermic machine preservation: A phase 1 (first-in-man) clinical trial. American Journal of Transplantation, 16(6), 1779–1787. https://pubmed.ncbi.nlm.nih.gov/26752191/.